Subcutaneous Methotrexate Switch Reduces Joint Inflammation in Real-World Rheumatoid Arthritis Study
A two-center observational study reveals that switching from oral to subcutaneous methotrexate reduces power Doppler-detected joint synovitis and improves clinical ...

